Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

794 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical course and prognosis of non-secretory multiple myeloma.
Chawla SS, Kumar SK, Dispenzieri A, Greenberg AJ, Larson DR, Kyle RA, Lacy MQ, Gertz MA, Rajkumar SV. Chawla SS, et al. Among authors: kumar sk. Eur J Haematol. 2015 Jul;95(1):57-64. doi: 10.1111/ejh.12478. Epub 2015 Jan 21. Eur J Haematol. 2015. PMID: 25382589
Clinical Course and Prognosis of Non-Secretory Multiple Myeloma.
Chawla SS, Kumar SK, Dispenzieri A, Greenberg AJ, Larson DR, Kyle RA, Lacy MQ, Gertz MA, Rajkumar SV. Chawla SS, et al. Among authors: kumar sk. Eur J Haematol. 2015 Feb 16. doi: 10.1111/ejh.12534. Online ahead of print. Eur J Haematol. 2015. PMID: 25690913
Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib.
Kumar SK, LaPlant BR, Reeder CB, Roy V, Halvorson AE, Buadi F, Gertz MA, Bergsagel PL, Dispenzieri A, Thompson MA, Crawley J, Kapoor P, Mikhael J, Stewart K, Hayman SR, Hwa YL, Gonsalves W, Witzig TE, Ailawadhi S, Dingli D, Go RS, Lin Y, Rivera CE, Rajkumar SV, Lacy MQ. Kumar SK, et al. Blood. 2016 Nov 17;128(20):2415-2422. doi: 10.1182/blood-2016-05-717769. Epub 2016 Oct 4. Blood. 2016. PMID: 27702799 Free PMC article. Clinical Trial.
Immune Therapies in Multiple Myeloma.
Kumar SK, Anderson KC. Kumar SK, et al. Clin Cancer Res. 2016 Nov 15;22(22):5453-5460. doi: 10.1158/1078-0432.CCR-16-0868. Clin Cancer Res. 2016. PMID: 28151713 Review.
Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy.
Dingli D, Ailawadhi S, Bergsagel PL, Buadi FK, Dispenzieri A, Fonseca R, Gertz MA, Gonsalves WI, Hayman SR, Kapoor P, Kourelis T, Kumar SK, Kyle RA, Lacy MQ, Leung N, Lin Y, Lust JA, Mikhael JR, Reeder CB, Roy V, Russell SJ, Sher T, Stewart AK, Warsame R, Zeldenrust SR, Rajkumar SV, Chanan Khan AA. Dingli D, et al. Among authors: kumar sk. Mayo Clin Proc. 2017 Apr;92(4):578-598. doi: 10.1016/j.mayocp.2017.01.003. Epub 2017 Mar 11. Mayo Clin Proc. 2017. PMID: 28291589 Free PMC article. Review.
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis.
Tandon N, Sidana S, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Dingli D, Fonder AL, Hobbs MA, Hayman SR, Gonsalves WI, Hwa YL, Kapoor P, Kyle RA, Leung N, Go RS, Lust JA, Russell SJ, Zeldenrust SR, Rajkumar SV, Kumar SK. Tandon N, et al. Among authors: kumar sk. Am J Hematol. 2017 Jun;92(6):549-554. doi: 10.1002/ajh.24723. Epub 2017 Apr 26. Am J Hematol. 2017. PMID: 28314084 Free article.
Treating Multiple Myeloma Patients With Oral Therapies.
Kumar SK, Vij R, Noga SJ, Berg D, Brent L, Dollar L, Chari A. Kumar SK, et al. Clin Lymphoma Myeloma Leuk. 2017 May;17(5):243-251. doi: 10.1016/j.clml.2017.02.024. Epub 2017 Mar 7. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28347676 Review.
794 results